Pharmaron Beijing Expects Up to 10% Rise in H1 Attributable Profit

MT Newswires18:29

《Major Brokerage》UBS Group: China's CRO industry posted solid revenue growth in the first half; names Wuxi Apptec (02359.HK) as top pick

UBS Group published a research report stating that a number of CDMO pharmaceutical companies will release their first-half earnings. Benefiting from robust demand for novel drug modalities and steady order momentum, their interim performance is expected to remain strong, supporting the firm's view that the sector will continue to outperform the broader market. The report forecasts strong second-quarter TIDES revenue growth for Wuxi Apptec (02359.HK), with full-year guidance pointing to approximately 40% year-over-year growth. Small-molecule business remains resilient, driven by GLP-1 and other new drugs, while the impact from the 1260H bill is expected to be limited. UBS has slightly raised its revenue forecasts for Wuxi Apptec for 2026–2028 and increased its net profit forecast by 0.5%, raising the target price from HK$171.

AASTOCKS15:11

Major Brokerage: UBS Group's Investment Rating and Target Price for CRO Shares (Table)

UBS Group published a research report listing the investment ratings and target prices for CRO shares as follows: Stock | Investment Rating | Target Price (HKD) Wuxi Apptec (02359.HK) | Buy | HK$171.2 → HK$176.5 Wuxi Bio (02269.HK) | Buy | HK$51.1 Wuxi XDC (02268.HK) | Buy | HK$89.4 → HK$87.4 Pharmaron (03759.HK) | Buy | HK$30 → HK$31.8 Tigermed (03347.HK) | Buy |

AASTOCKS14:49

Hong Kong Market Midday Review | All three major indices declined, with the Hang Seng Tech Index down 1.42%; tech and internet stocks weakened, Baidu fell nearly 9%; PCB-related stocks and oil equities rose, with Kingboard Laminates up nearly 8% and Petro

Tech and internet stocks declined, with Baidu Group-SW down 8.84% and SenseTime-W down 5.26%; smartphone supply chain stocks broadly fell, with Hua Hong Hongli down 5.98%, while Kingboard Group rose 3.87%; oil stocks strengthened, with PetroChina up 3.35% and CNOOC up 2.34%;

Futu News12:10

Hong Kong Market Midday Review | Hang Seng Index Down 0.47% in Morning Session; Oil Stocks Rise Against the Trend

Most oil stocks rose, with ongoing risks of escalating tensions in the Middle East; the 'Big Three' oil companies are expected to fully benefit from higher oil prices in their Q2 earnings.

Zhitong Finance12:00

Hong Kong Stock Market Movement | Pharmaron (03759.HK) Reverses to Gain Over 6% as H1 Net Profit Forecast Rises 4%–10%; CMC Orders Expected to Unlock Growth Potential

Pharmaron (03759.HK) declined in early trading but turned positive before noon, rising more than 6%. As of the time of writing, it was up 4.95% at HK$23.30, with a turnover of HK$267 million.

Zhitong Finance11:03